Insmed Incorporated today announced that management will present at the Nasdaq 49th Investor Conference in London on Wednesday, December 6, 2023 , at 8:30 a.m. ET / 1:30 p.m. GMT.
BRIDGEWATER, N.J., Nov. 29, 2023 /PRNewswire/ --Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that management will present at the Nasdaq 49th Investor Conference in London on Wednesday, December 6, 2023, at 8:30 a.m. ET/1:30 p.m. GMT. The fireside chat will be webcast live and can be accessed by visiting the investor relations section of the Company’s website at www.insmed.com. The webcast will be archived for a period of 30 days following the conclusion of the live event. About Insmed Contact: Investors: Bryan Dunn Eleanor Barisser Media:
View original content to download multimedia:https://www.prnewswire.com/news-releases/insmed-to-present-at-the-nasdaq-49th-investor-conference-301999721.html SOURCE Insmed Incorporated | ||
Company Codes: NASDAQ-NMS:INSM |